SNORD33 and cancer: In addition to snoRNA42, they identified SNORD33, SNORD66, SNORD73B, SNORD76 and SNORD78. Of these, SNORD33, SNORD66, and SNORD76 expression in the plasma of NSCLC patients was higher compared to cancer-free individuals [138].